ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,505Medicare Part D Prescriptions Filled, Including Refills

Rank: 76 out of 625

$738K Total Retail Price of All Prescriptions

Rank: 78 out of 625

678 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 678 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

8% of this provider’s 678 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 9,119 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
SIMVASTATIN 446 379 1 2
TRAMADOL HCL 363 262 2 16
LEVOTHYROXINE SODIUM 360 277 3 3
PRAVASTATIN SODIUM 346 261 4 8
METFORMIN HCL 341 244 5 10
AMLODIPINE BESYLATE 332 291 6 1
OMEPRAZOLE 326 222 7 6
LISINOPRIL 298 199 8 5
FUROSEMIDE 245 189 9 7
ATORVASTATIN CALCIUM 230 180 10 9
GABAPENTIN 224 142 11 14
HYDROCHLOROTHIAZIDE 220 186 12 12
ATENOLOL 195 174 13 22
METOPROLOL TARTRATE 193 149 14 11
ALENDRONATE SODIUM 189 160 15 34
CRESTOR 152 91 16 17
DONEPEZIL HCL 148 144 17 33
HYDROCODONE-ACETAMINOPHEN 146 76 S3 18 4
CLOPIDOGREL 145 121 19 30
NEXIUM 129 78 20 21
FLUTICASONE PROPIONATE 125 98 21 32
LOSARTAN POTASSIUM 123 92 22 18
BENAZEPRIL HCL 122 84 23 35
NAMENDA 119 117 24 45
TRAZODONE HCL 115 61 25 51
POTASSIUM CHLORIDE 114 93 26 19
GLIMEPIRIDE 114 107 26 42
OXYCODONE-ACETAMINOPHEN 102 51 S2 28 95
SERTRALINE HCL 102 76 28 26
CITALOPRAM HBR 99 91 30 24
LOSARTAN-HYDROCHLOROTHIAZIDE 98 94 31 38
PROAIR HFA 97 58 32 57
PLAVIX 96 82 33 43
GLYBURIDE 90 62 R 34 106
GLIPIZIDE 87 44 35 56
WARFARIN SODIUM 85 62 36 20
ALLOPURINOL 84 67 37 29
AZITHROMYCIN 82 55 38 40
DIOVAN HCT 79 41 39 52
RAMIPRIL 75 74 40 78
PREDNISONE 74 55 41 37
ZETIA 73 45 42 66
ENALAPRIL MALEATE 71 57 43 81
TAMSULOSIN HCL 69 64 44 36
LEVOFLOXACIN 69 33 44 90
ADVAIR DISKUS 67 52 46 63
CLONIDINE HCL 67 57 46 50
METOPROLOL SUCCINATE 66 46 48 15
OXYCONTIN 66 13 S2 48 174
VESICARE 66 41 48 193
SYNTHROID 65 50 51 39
AMITRIPTYLINE HCL 65 38 R 51 61
SPIRIVA 63 41 53 70
GLYBURIDE-METFORMIN HCL 63 48 R 53 125
ROPINIROLE HCL 61 50 55 96
AMOX TR-POTASSIUM CLAVULANATE 60 43 56 135
DIOVAN 59 52 57 28
GEMFIBROZIL 58 37 58 127
CIPROFLOXACIN HCL 56 48 59 60
CARVEDILOL 55 48 60 23
DILTIAZEM 24HR CD 53 45 61 131
DIGOXIN 53 51 61 55
ZOLPIDEM TARTRATE 52 27 63 13
PAROXETINE HCL 52 28 63 76
NOVOLIN 70-30 52 43 63 154
POLYETHYLENE GLYCOL 3350 50 28 66 82
PROMETHAZINE HCL 50 23 R 66 84
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 10, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.